Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01796392 · ClinicalTrials.gov registry record · NA
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
A NA study, sponsored by Pulmonx Corporation.
- Completed
- Registry status
- NA
- Development phase
- 190
- Enrollment target
NCT01796392: Completed NA study, sponsored by Pulmonx Corporation.
NCT01796392 is a NA study that has completed, run by Pulmonx Corporation. The registered enrollment target is 190 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01796392, a NA study, has completed, sponsored by Pulmonx Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 190 participants
- Enrollment target
Study Summary
The purpose of this research is to study an investigational medical device that is designed to produce lung volume reduction in diseased areas of the lungs in patients with severe emphysema.
Primary Outcome
The percentage of study participants in the Zephyr Valve EBV (Endobronchial Valves) treatment arm meeting the clinically significant threshold of \>15% improved forced expiratory volume in one second (FEV1), obtained immediately following bronchodilator therapy, as compared to the percentage in the control arm at 1 year post-procedure.
Interventions
- DEVICE EBV
- OTHER Optimal Medical Management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 190 participants |
| Start Date | 2013-07 |
| Est. Completion | 2023-04 |
| Phase | NA |
What the finished NCT01796392 record still lists
NCT01796392 is an interventional study that assigns participants to a tested intervention. The registered 190 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 2 interventions - of which EBV is the first listed.
NCT01796392 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01796392 about?
NCT01796392 is a clinical study titled "Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)". The purpose of this research is to study an investigational medical device that is designed to produce lung volume reduction in diseased areas of the lungs in patients with severe emphysema.
What is the current status of trial NCT01796392?
This trial is currently completed. It is a NA study. The enrollment target is 190 participants. The study started on 2013-07. Estimated completion is 2023-04.
What interventions are being tested in trial NCT01796392?
The interventions under investigation include: EBV (DEVICE), Optimal Medical Management (OTHER).
Who is sponsoring clinical trial NCT01796392?
This trial is sponsored by Pulmonx Corporation, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01796392's enrollment target sits among peer trials
190 574th of 2000 higher than 1,425 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03257033 · 190 participants · Phase 3
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
- NCT03642028 · 190 participants · Phase 4
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress
- NCT04015609 · 190 participants · NA
Psychotherapy Intervention for Latinos With Advanced Cancer
- NCT04284397 · 190 participants · Early Phase 1
Identification of Critical Thermal Environments for Aged Adults
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia